Monte Rosa Correlations

GLUE Stock  USD 20.93  0.05  0.24%   
The current 90-days correlation between Monte Rosa Therapeutics and Day One Biopharmaceuticals is 0.18 (i.e., Average diversification). The correlation of Monte Rosa is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Monte Rosa Correlation With Market

Poor diversification

The correlation between Monte Rosa Therapeutics and DJI is 0.78 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Monte Rosa Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Moving together with Monte Stock

  0.72DSGN Design TherapeuticsPairCorr
  0.7ENGN enGene Holdings CommonPairCorr
  0.75IMMP Immutep Ltd ADRPairCorr
  0.89MRKR Marker TherapeuticsPairCorr
  0.74AVE Avecho BiotechnologyPairCorr
  0.84ANNX AnnexonPairCorr
  0.62SLDB Solid Biosciences LLCPairCorr
  0.81AVCR Avricore HealthPairCorr
  0.77BOLT Bolt BiotherapeuticsPairCorr
  0.88TNGX Tango TherapeuticsPairCorr
  0.65CADL Candel TherapeuticsPairCorr

Moving against Monte Stock

  0.84GNLX Genelux CommonPairCorr
  0.79DWTX Dogwood TherapeuticsPairCorr
  0.76LYRA Lyra TherapeuticsPairCorr
  0.72ABP Abpro HoldingsPairCorr
  0.69EDIT Editas MedicinePairCorr
  0.62IMRN Immuron Ltd ADRPairCorr
  0.61KURA Kura OncologyPairCorr
  0.56EVGN EvogenePairCorr
  0.55QSI QuantumSiPairCorr
  0.41KRRO Frequency TherapeuticsPairCorr
  0.33LRMR Larimar TherapeuticsPairCorr
  0.76PRQR ProQR TherapeuticsPairCorr
  0.76ACXP Acurx Pharmaceuticals LLCPairCorr
  0.66MREO Mereo BioPharma GroupPairCorr
  0.58MBIO Mustang BioPairCorr
  0.5PROK ProKidney CorpPairCorr
  0.4AURA Aura BiosciencesPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

AVBPARVN
VIRARVN
TBPHARVN
VIRAVBP
VIRGERN
TBPHDAWN
  

High negative correlations

REPLDAWN
VALNREPL
MGTXTBPH
DNATBPH
MGTXDAWN
DNAARVN

Risk-Adjusted Indicators

There is a big difference between Monte Stock performing well and Monte Rosa Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Monte Rosa's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
DAWN  4.35  0.87  0.21  1.53  3.61 
 13.81 
 39.62 
ARVN  3.06  0.60  0.16  2.94  3.12 
 5.91 
 28.90 
REPL  2.58 (0.47) 0.00 (0.78) 0.00 
 5.56 
 14.00 
TBPH  2.23  0.54  0.21  0.71  2.14 
 3.82 
 28.70 
AVBP  2.96  0.32  0.10  0.47  3.00 
 6.71 
 18.12 
GERN  2.81  0.27  0.10  0.16  2.84 
 7.76 
 16.99 
VIR  3.34  0.41  0.11  0.27  3.40 
 8.08 
 20.46 
DNA  3.35 (0.39) 0.00  1.98  0.00 
 8.16 
 28.96 
VALN  2.20  0.03  0.00  0.57  2.35 
 4.83 
 15.59 
MGTX  2.52 (0.19) 0.00 (0.07) 0.00 
 5.08 
 14.00 

Monte Rosa Corporate Management

Filip MDChief OfficerProfile
Jennifer ChampouxVP OperationsProfile
Sharon TownsonChief OfficerProfile
Edmund DunnSenior ControllerProfile
John CastleChief ScientistProfile
Magnus DPHILSenior DevelopmentProfile